← Leaderboards
Qiaoqiang Gan
State University Of New York At Buffalo
$282,714
Attributed
$565,427
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $206.4K · FY2019–21$250K$187.5K$125K$62.5K$0
'19
'20
'21
Funding mix
By agency
NIH$565,427 · 1
By mechanism
R21$565,427 · 1
Top collaborators
- Yun Wu3 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Sriram Neelamegham$14,753,332
- Yun Wu$3,163,825
- Grace Dy$1,167,635
- Daniel Jaremko$159,836
- Paul D Gollnick$3,138,867
Others in their field
Other Emerging Leaders on “Advanced Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$378,174,673
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Kimberly Smith · Ppd Development Lp$115,671,664
Research focus
Advanced DevelopmentAffectAntibodiesBaseBenignBiobankBiochipBiological MarkersBiomarker DiscoveryBiometryBiosensorBuffaloesCancer BiomarkersCancer CellCancer DiagnosisCancer DiagnosticsCancer PatientCell Culture TechniquesCellsCirculating BiomarkersCohortColonoscopyColorectal CancerA549
Grant awards (3)
Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection$206,392
R21 · FY2021 · CA
Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection$175,266
R21 · FY2020 · CA
Exosome-Protein-microRNA-OneStop (Exo-PROS) biosensor: a new liquid biopsy for cancer screening and early detection$183,769
R21 · FY2019 · CA